US Stock MarketDetailed Quotes

LEGN Legend Biotech

Watchlist
  • 35.840
  • -2.060-5.44%
Close Dec 11 16:00 ET
  • 35.840
  • 0.0000.00%
Post 20:01 ET
6.60BMarket Cap-18.67P/E (TTM)

About Legend Biotech Company

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Company Profile

SymbolLEGN
Company NameLegend Biotech
Listing DateJun 5, 2020
Issue Price23.00
Founded2014
CEODr. Ying Huang, PhD
MarketNASDAQ
Employees1826
Securities TypeDR
ADS Ratio1.0 : 2.0
Fiscal Year Ends12-31
Address2101 Cottontail Lane
CitySomerset
ProvinceNew Jersey
CountryUnited States of America
Zip Code08873
Phone1-737-317-5050

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Ying Huang, PhD
  • Director and Chief Executive Officer
  • --
  • Lori Macomber, C.P.A.
  • Chief Financial Officer
  • --
  • Dr. Fangliang Zhang, PhD
  • Chairman of the Board
  • --
  • Dr. Li Zhu, PhD
  • Director
  • --
  • Ye Wang, M.S.
  • Director
  • --
  • Tomas J. Heyman
  • Independent Director
  • --
  • Li Mao, M.D.
  • Independent Director
  • --
  • Dr. Darren Xiaohui Ji, M.D.,PhD
  • Independent Director
  • --
  • Wai Man Philip Yau, C.P.A.
  • Independent Director
  • --
  • Dr. Patrick Casey, PhD
  • Independent Director
  • --
  • Dr. Corazon Dating Sanders, PhD
  • Independent Director
  • --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.